Verve Therapeutics🇺🇸
📈 Listed (VERV)
Gene EditingCambridgeEst. 2018👤 150 employees📍 VERV
📊
AMORA SCORE
📊
AMORA Score not yet available
This company is being evaluated across 5 dimensions: Advancement, Mastery, Operations, Reach, and Affinity.
Learn how AMORA Score works →ABOUT
In vivo base editing for cardiovascular disease. Heart-1 trial targeting PCSK9.
Pro Intelligence
Unlock full company profile
Access detailed funding data, AMORA scores, technology stack, supply chain position, and customer analysis.
Subscribe Now — $19.9/mo →🔒 Cancel anytime📦 Instant access🌍 500+ analysts trust AMORA
Already subscribed? Sign in to access.
Share this report